Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes

被引：7
|
作者：
Moya Chimenti, Elisa [1 ]
Herranz de la Morena, Lucrecia [2 ]
Martin Vaquero, Pilar [2 ]
Saez-de-ibarra, Lourdes [2 ]
Garcia Dominguez, Maria [3 ]
Pallardo Sanchez, Luis Felipe [2 ]
机构：
[1] Hosp Infanta Cristina, Dept Endocrinol, Madrid 28981, Spain
[2] La Paz Univ Hosp, Dept Endocrinol, Madrid 28046, Spain
[3] Hosp Sureste, Dept Endocrinol, Madrid 28500, Spain
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2010年 / 90卷 / 03期
关键词：
Continuous subcutaneous insulin infusion (CSII); Diabetes mellitus Type 1 (T1DM); Glycaemic control; PUMP THERAPY; CHILDREN; MELLITUS;
D O I：
10.1016/j.diabres.2010.08.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We evaluated glycaemic variability with continuous glucose monitoring system in 31 people with Type 1 diabetes mellitus using multiple daily injections initially and after switching to continuous subcutaneous insulin infusion. There was a significant improvement in HbA1c, mean glucose, standard deviation of mean glucose and in hyperglycaemic excursions with CSII. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：E57 / E59
页数：3
相关论文
共 50 条
  • [41] Vascular function and glucose variability improve transiently following initiation of continuous subcutaneous insulin infusion in children with type 1 diabetes
    Harrington, Jennifer
    Pena, Alexia S.
    Wilson, Louise
    Gent, Roger
    Dowling, Kate
    Baghurst, Peter
    Couper, Jennifer
    PEDIATRIC DIABETES, 2013, 14 (07) : 504 - 511
  • [42] Continuous subcutaneous insulin infusion (CSII) in type 2 diabetes: reductions in HbA1c - mean glucose and variability
    Anhalt, H.
    Rodbard, D.
    Bailey, T.
    Bode, B. W.
    Brunelle, R.
    Edelman, S.
    Frias, J. P.
    Kipnes, M. S.
    DIABETOLOGIA, 2011, 54 : S400 - S400
  • [43] Reducing glucose variability with continuous subcutaneous insulin infusion increases endothelial progenitor cells in type 1 diabetes: an observational study
    Maria Ida Maiorino
    Ofelia Casciano
    Elisabetta Della Volpe
    Giuseppe Bellastella
    Dario Giugliano
    Katherine Esposito
    Endocrine, 2016, 52 : 244 - 252
  • [44] Is It Time for a Revolution? The Role of Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring in Improving Care of Patients With Type 1 Diabetes Mellitus-Introduction
    Grunberger, George
    ENDOCRINE PRACTICE, 2012, 18 : 7 - 9
  • [45] Better treatment of outpatients with type 1 diabetes after introduction of continuous subcutaneous insulin infusion
    Marmolin, Ea Sofie
    Brodsgaard, Jane
    Gjessing, Hans Jorgen
    Schousboe, Karoline
    Grodum, Ellen
    Jorgensen, Ulla Linding
    Moller, Charlotte Chrois
    Pedersen, Jette
    DANISH MEDICAL JOURNAL, 2012, 59 (06):
  • [46] Effects of meals with different glycaemic index on postprandial blood glucose response in patients with Type 1 diabetes treated with continuous subcutaneous insulin infusion
    Parillo, M.
    Annuzzi, G.
    Rivellese, A. A.
    Bozzetto, L.
    Alessandrini, R.
    Riccardi, G.
    Capaldo, B.
    DIABETIC MEDICINE, 2011, 28 (02) : 227 - 229
  • [47] The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes
    Johnson, Susan L.
    McEwen, Laura N.
    Newton, Christopher A.
    Martin, Catherine L.
    Raskin, Philip
    Halter, Jeffrey B.
    Herman, William H.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2011, 25 (04) : 211 - 215
  • [48] Pascal's Wager: Combining Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion
    Kerr, David
    Olateju, Tolu
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 : S43 - S50
  • [49] Prevalence of and Reasons for Discontinuation of Continuous Subcutaneous Insulin Infusion in People with Type 1 Diabetes: A Systematic Review
    Dekker, Pim
    Aanstoot, Henk-Jan
    Sas, Theo
    de Vries, Martine
    Birnie, Erwin
    Mul, Dick
    Nefs, Giesje
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (08) : 559 - 570
  • [50] Reduced fear of hypoglycaemia with continuous subcutaneous insulin infusion (CSII) therapy in people with Type 1 diabetes
    Davenport, K.
    Ng, S.
    Chen, J.
    Ebsworth, T.
    Ward, C.
    Evans, M. L.
    DIABETIC MEDICINE, 2013, 30 : 147 - 147
12345